Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study

CONCLUSIONS: At least three doses of PCV13 continue to be effective in preventing VT-IPD among children aged < 5 years in the US. PCV13 was protective against serotypes 19A and 19F IPD; protection against serotype 3 IPD did not reach statistical significance.PMID:38704263 | DOI:10.1016/j.vaccine.2024.04.061

Source: Vaccine - May 4, 2024 Category: Allergy & Immunology Authors: Kristin L Andrejko Ryan Gierke Jemma V Rowlands Jennifer B Rosen Ann Thomas Zachary Q Landis Maria Rosales Sue Petit William Schaffner Corinne Holtzman Meghan Barnes Monica M Farley Lee H Harrison Lesley McGee Sopio Chochua Jennifer R Verani Adam L Cohen Source Type: research